These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 33023325)

  • 21. Impact of Procedural Bleeding in Peripheral Artery Disease: An Analysis From EUCLID Trial.
    Kansal A; Huang Z; Rockhold FW; Baumgartner I; Berger JS; Blomster JI; Fowkes FG; Katona B; Mahaffey KW; Norgren L; Hiatt WR; Patel MR; Jones WS
    Circ Cardiovasc Interv; 2019 Oct; 12(10):e008069. PubMed ID: 31581789
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ticagrelor versus clopidogrel in patients with symptomatic peripheral artery disease and prior coronary artery disease: Insights from the EUCLID trial.
    Berger JS; Abramson BL; Lopes RD; Heizer G; Rockhold FW; Baumgartner I; Fowkes FGR; Held P; Katona BG; Norgren L; Jones WS; Millegård M; Blomster J; Reist C; Hiatt WR; Patel MR; Mahaffey KW
    Vasc Med; 2018 Dec; 23(6):523-530. PubMed ID: 29992857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Different Mid-Term Prognostic Predictors of Major Adverse Events in Diabetic and Nondiabetic Peripheral Artery Disease Presenting With Critical Limb Ischemia.
    Liang KW; Kuo HN; Lee WL; Liu TJ; Lin WW; Tsao CR; Ting CT; Wang KY
    Angiology; 2016 Mar; 67(3):287-91. PubMed ID: 23389094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of severe chronic kidney disease on outcomes of infrainguinal peripheral arterial intervention.
    Patel VI; Mukhopadhyay S; Guest JM; Conrad MF; Watkins MT; Kwolek CJ; LaMuraglia GM; Cambria RP
    J Vasc Surg; 2014 Feb; 59(2):368-75. PubMed ID: 24176634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peripheral Revascularization in Patients With Peripheral Artery Disease With Vorapaxar: Insights From the TRA 2°P-TIMI 50 Trial.
    Bonaca MP; Creager MA; Olin J; Scirica BM; Gilchrist IC; Murphy SA; Goodrich EL; Braunwald E; Morrow DA
    JACC Cardiovasc Interv; 2016 Oct; 9(20):2157-2164. PubMed ID: 27765312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcomes of bypass and endovascular interventions for advanced femoropopliteal disease in patients with premature peripheral artery disease.
    Kim TI; Zhang Y; Cardella JA; Guzman RJ; Ochoa Chaar CI
    J Vasc Surg; 2021 Dec; 74(6):1968-1977.e3. PubMed ID: 34090986
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nationwide Trends in Hospital Outcomes and Utilization After Lower Limb Revascularization in Patients on Hemodialysis.
    Garimella PS; Balakrishnan P; Correa A; Poojary P; Annapureddy N; Chauhan K; Patel A; Patel S; Konstantinidis I; Chan L; Agarwal SK; Jaar BG; Gidwani U; Matsushita K; Nadkarni GN
    JACC Cardiovasc Interv; 2017 Oct; 10(20):2101-2110. PubMed ID: 29050629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Review of Antithrombotic Therapies for Patients with Chronic Peripheral Arterial Disease and after Revascularization.
    Skeik N; Jordano L; Robinson EC; Mirza AK; Manunga J
    Angiology; 2022 Mar; 73(3):197-206. PubMed ID: 35086344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of graft patency, limb salvage, and antithrombotic therapy between prosthetic and autogenous below-knee bypass for critical limb ischemia.
    Suckow BD; Kraiss LW; Stone DH; Schanzer A; Bertges DJ; Baril DT; Cronenwett JL; Goodney PP;
    Ann Vasc Surg; 2013 Nov; 27(8):1134-45. PubMed ID: 24011814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antithrombotic Therapy After Revascularization in Patients With Peripheral Arterial Disease: What Is Here, What Is Next.
    Amer MR; Chaturvedula ST; Joshi S; Ingrassia J
    Vasc Endovascular Surg; 2019 May; 53(4):325-336. PubMed ID: 30885060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery Disease.
    Bonaca MP; Bhatt DL; Storey RF; Steg PG; Cohen M; Kuder J; Goodrich E; Nicolau JC; Parkhomenko A; López-Sendón J; Dellborg M; Dalby A; Špinar J; Aylward P; Corbalán R; Abola MTB; Jensen EC; Held P; Braunwald E; Sabatine MS
    J Am Coll Cardiol; 2016 Jun; 67(23):2719-2728. PubMed ID: 27046162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Major Limb Outcomes Following Lower Extremity Endovascular Revascularization in Patients With and Without Diabetes Mellitus.
    Shammas AN; Jeon-Slaughter H; Tsai S; Khalili H; Ali M; Xu H; Rodriguez G; Cawich I; Armstrong EJ; Brilakis ES; Banerjee S
    J Endovasc Ther; 2017 Jun; 24(3):376-382. PubMed ID: 28440113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment outcomes in diabetic patients with chronic limb-threatening ischemia.
    Liang P; Soden PA; Zettervall SL; Shean KE; Deery SE; Guzman RJ; Hamdan AD; Schermerhorn ML
    J Vasc Surg; 2018 Aug; 68(2):487-494. PubMed ID: 29576404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Do we have a unified consensus on antithrombotic management of PAD?
    Poredos P; Antignani PL; Blinc A; Fras Z; Jezovnik MK; Fareed J; Mansilha A
    Int Angiol; 2021 Jun; 40(3):229-239. PubMed ID: 33739074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neutrophil-lymphocyte ratio predicts disease severity and outcome after lower extremity procedures.
    Bath J; Smith JB; Kruse RL; Vogel TR
    J Vasc Surg; 2020 Aug; 72(2):622-631. PubMed ID: 31882318
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical presentation and outcome after failed infrainguinal endovascular and open revascularization in patients with chronic limb ischemia.
    Dosluoglu HH; Lall P; Blochle R; Harris LM; Dryjski ML
    J Vasc Surg; 2013 Jul; 58(1):98-104.e1. PubMed ID: 23683380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-compressible ABIs are associated with an increased risk of major amputation and major adverse cardiovascular events in patients with critical limb ischemia.
    Singh GD; Armstrong EJ; Waldo SW; Alvandi B; Brinza E; Hildebrand J; Amsterdam EA; Humphries MD; Laird JR
    Vasc Med; 2017 Jun; 22(3):210-217. PubMed ID: 28466753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High plateletcrit is associated with early loss of patency after open and endovascular interventions for chronic limb ischemia.
    Khan SZ; Dosluoglu HH; Pourafkari L; Rivero M; Nader ND
    J Vasc Surg; 2020 Jun; 71(6):2089-2097. PubMed ID: 31708302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of Sex Differences in 5-Year Clinical Outcomes Following Endovascular Revascularization for Peripheral Artery Disease.
    Lee MS; Choi BG; Hollowed J; Han SK; Baek MJ; Gi Ryu Y; Choi SY; Byun JK; Mashaly A; Park Y; Jang WY; Kim W; Choi JY; Park EJ; Na JO; Choi CU; Kim EJ; Park CG; Seo HS; Rha SW
    Cardiovasc Revasc Med; 2020 Jan; 21(1):110-115. PubMed ID: 31072790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Statin use in patients with peripheral arterial disease.
    Harris SK; Roos MG; Landry GJ
    J Vasc Surg; 2016 Dec; 64(6):1881-1888. PubMed ID: 27871503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.